Evidence map›Paper›PMID 34400895›Full record

ArticleInternational journal of medical sciences2021

Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology.

Jayoung Kim, Austin Yeon, Sarah J Parker, Muhammad Shahid, Aissatou Thiombane, Eunho Cho, Sungyong You, Hany Emam, Do-Gyoon Kim, Minjung Kim

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jayoung KimDepartments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Austin YeonDepartments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sarah J ParkerSmidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Muhammad ShahidDepartments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Aissatou ThiombaneDepartments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Eunho ChoDepartments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sungyong YouDepartments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Hany EmamDivision of Orthodontics, College of Dentistry, The Ohio State University, Columbus, OH, USA.
Do-Gyoon KimDivision of Oral Surgery, College of Dentistry, The Ohio State University, Columbus, OH, USA.
Minjung KimDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, USA.
Cedars-Sinai Medical Center · USThe Ohio State University · USUniversity of California, Los Angeles · USUniversity of South Florida · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Microbiome and Proteome As Predictive Biomarkers of UCPPSU01DK103260 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI ANGER, JENNIFER TASH, FREEMAN, MICHAEL R · 2014 to 2018
$1.2M
Urinary Metabolites in IC PBS DiagnosisR01DK100974 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI ANGER, JENNIFER TASH, KIM, JAYOUNG · 2013 to 2013
$416k
ACL HHS U01DP006079NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001881NCCDPHP CDC HHS U01 DP006079NIDDK NIH HHS R01 DK100974NIDDK NIH HHS U01 DK103260NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlendronateBisphosphonate-Associated Osteonecrosis of the JawBone and BonesBone Density Conservation AgentsCell Line, TumorGlycogen Synthase Kinase 3HumansHuman Umbilical Vein Endothelial CellsOsteogenesisOsteoporosis, PostmenopausalOsteoporotic FracturesProteomeProteomicsReceptor-Interacting Protein Serine-Threonine KinasesWnt Signaling PathwayAlendronateBone Density Conservation AgentsGlycogen Synthase Kinase 3ProteomeReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanbiomarkerbisphosphonatebone mineral densityclinical cone beam computed tomographyGSK signalingOsteonecrosis of the jawproteomics

Identifiers

PMID34400895
PMCPMC8364444
OpenAlexW3189555862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.